The FDA accepts the NDA for lorundrostat, a selective aldosterone synthase inhibitor, for adults with uncontrolled or resistant hypertension.
SAN DIEGO, CA—Renal denervation using ultrasound may be more effective than radiofrequency ablation for lowering blood pressure in patients with resistant hypertension, a preliminary head-to-head ...
– Lorundrostat, a highly selective aldosterone synthase inhibitor, demonstrated robust, double-digit reduction in systolic blood pressure (BP) with a well-tolerated profile – – Enhanced reduction in ...
MINNEAPOLIS, MN — The SYMPLICITY HTN-3 trial, a phase 3 study testing catheter-based renal denervation for the treatment of resistant hypertension, failed to achieve its primary efficacy end point, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “In this final follow-up from the SIMPLICITY HTN-3 trial ...
CHICAGO, IL—In the expanded SPYRAL HTN-ON MED trial, renal denervation with the Symplicity Spyral multielectrode catheter (Medtronic) failed to meet its primary endpoint in terms of blood ...
It's almost impossible to keep up with what things mean on TikTok, which is mostly thanks to the users who come up with phrases, memes, and acronyms almost daily. And when one sticks, you'd better be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results